James C Blair insider trades: Clovis Oncology (CLVS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where James reports to the SEC
and 31 more companies
Open-market buys and sales
213 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 20, 2019 | CLVS | ↑ Buy | 20,000 | $5.97 | $119K | By wife | Aug 20, 2019 (0d) |
| Aug 16, 2019 | CLVS | ↑ Buy | 20,000 | $5.70 | $114K | Direct | Aug 20, 2019 (4d) |
| Aug 6, 2019 | OBLN | ↑ Buy | 250,000 | $4.00 | $1.0M | Direct | Aug 8, 2019 (2d) |
| Mar 14, 2019 | CLVS | ↓ Sell | 17,056 | $27.79 | $474K | By DP VII Associates, L.P. | Mar 18, 2019 (4d) |
| Aug 23, 2018 | OBLN | ↑ Buy | 1,648,359 | $1.82 | $3.0M | Direct | Aug 27, 2018 (4d) |
| Aug 23, 2018 | BNGO | ↑ Buy | 15,000 | $6.13 | $92K | Direct | Aug 27, 2018 (4d) |
| Aug 4, 2017 | CLVS | ↓ Sell | 18,450 | $78.61 | $1.5M | By DP VII Associates, L.P. | Aug 8, 2017 (4d) |
| Aug 3, 2016 | CLCD | ↓ Sell | 153,028 | $8.45 | $1.3M | Direct | Aug 3, 2016 (0d) |
| Aug 3, 2016 | CLCD | ↓ Sell | 245 | $8.45 | $2K | Direct | Aug 3, 2016 (0d) |
| May 26, 2016 | EVOK | ↓ Sell | 344,120 | $4.70 | $1.6M | Direct | May 27, 2016 (1d) |
| May 26, 2016 | EVOK | ↓ Sell | 5,880 | $4.70 | $28K | Direct | May 27, 2016 (1d) |
| Apr 28, 2016 | CLCD | ↓ Sell | 149,765 | $6.96 | $1.0M | Direct | May 2, 2016 (4d) |
| Apr 28, 2016 | CLCD | ↓ Sell | 235 | $6.96 | $2K | Direct | May 2, 2016 (4d) |
| Apr 27, 2016 | EVOK | ↓ Sell | 5,095 | $5.07 | $26K | Direct | Apr 27, 2016 (0d) |
| Apr 27, 2016 | EVOK | ↓ Sell | 82 | $5.07 | $415 | Direct | Apr 27, 2016 (0d) |
| Apr 20, 2016 | EVOK | ↓ Sell | 41,478 | $5.35 | $222K | Direct | Apr 21, 2016 (1d) |
| Apr 20, 2016 | EVOK | ↓ Sell | 708 | $5.35 | $4K | Direct | Apr 21, 2016 (1d) |
| Apr 11, 2016 | EVOK | ↓ Sell | 4,348 | $5.22 | $23K | Direct | Apr 13, 2016 (2d) |
| Apr 11, 2016 | EVOK | ↓ Sell | 75 | $5.22 | $392 | Direct | Apr 13, 2016 (2d) |
| Apr 8, 2016 | EVOK | ↓ Sell | 51,004 | $5.28 | $269K | Direct | Apr 8, 2016 (0d) |
| Apr 8, 2016 | EVOK | ↓ Sell | 874 | $5.28 | $5K | Direct | Apr 8, 2016 (0d) |
| Aug 18, 2015 | EVOK | ↓ Sell | 11,836 | $7.02 | $83K | Direct | Aug 20, 2015 (2d) |
| Aug 18, 2015 | EVOK | ↓ Sell | 202 | $7.02 | $1K | Direct | Aug 20, 2015 (2d) |
| May 4, 2015 | TBRA | ↑ Buy | 277,777 | $10.62 | $2.9M | Direct | May 6, 2015 (2d) |
| Apr 16, 2015 | EVOK | ↓ Sell | 50,163 | $7.29 | $366K | Direct | Apr 16, 2015 (0d) |
| Apr 16, 2015 | EVOK | ↓ Sell | 857 | $7.29 | $6K | Direct | Apr 16, 2015 (0d) |
| Mar 5, 2015 | CLVS | ↓ Sell | 8,528 | $77.70 | $663K | By DP VII Associates, L.P. | Mar 5, 2015 (0d) |
| Nov 25, 2014 | NEOT | ↑ Buy | 70,000 | $14.00 | $980K | Direct | Nov 26, 2014 (1d) |
| Oct 21, 2014 | ESPR | ↑ Buy | 500,000 | $20.00 | $10.0M | Direct | Oct 21, 2014 (0d) |
| Oct 21, 2014 | ATRA | ↑ Buy | 248,159 | $11.00 | $2.7M | Direct | Oct 21, 2014 (0d) |
| Oct 21, 2014 | ATRA | ↑ Buy | 1,841 | $11.00 | $20K | Direct | Oct 21, 2014 (0d) |
| Aug 5, 2014 | MRNS | ↑ Buy | 419,744 | $8.00 | $3.4M | Direct | Aug 7, 2014 (2d) |
| Jan 16, 2014 | ALIM | ↓ Sell | 296,760 | $6.39 | $1.9M | Direct | Jan 17, 2014 (1d) |
| Jan 16, 2014 | ALIM | ↓ Sell | 3,240 | $6.39 | $21K | Direct | Jan 17, 2014 (1d) |
| Aug 27, 2013 | RGDO | ↑ Buy | 750,000 | $4.00 | $3.0M | By Domain Partners VI, L.P. | Aug 28, 2013 (1d) |
| Jul 15, 2013 | OCRX | ↑ Buy | 988,285 | $6.03 | $6.0M | By Domain Partners VIII, L.P. | Jul 16, 2013 (1d) |
| Jul 15, 2013 | OCRX | ↑ Buy | 331,873 | $6.03 | $2.0M | By Domain Partners VI, L.P. | Jul 16, 2013 (1d) |
| Jul 15, 2013 | OCRX | ↑ Buy | 7,333 | $6.03 | $44K | By DP VIII Associates, L.P. | Jul 16, 2013 (1d) |
| Jul 1, 2013 | ESPR | ↑ Buy | 280,923 | $14.00 | $3.9M | By Domain Partners VII, L.P. | Jul 2, 2013 (1d) |
| Jul 1, 2013 | ESPR | ↑ Buy | 4,791 | $14.00 | $67K | By DP VII Associates, L.P. | Jul 2, 2013 (1d) |
| Jun 20, 2013 | ALIM | ↓ Sell | 10,516 | $5.01 | $53K | Direct | Jun 24, 2013 (4d) |
| Jun 20, 2013 | ALIM | ↓ Sell | 114 | $5.01 | $571 | Direct | Jun 24, 2013 (4d) |
| Jun 19, 2013 | ALIM | ↓ Sell | 55,278 | $5.39 | $298K | Direct | Jun 20, 2013 (1d) |
| Jun 19, 2013 | ALIM | ↓ Sell | 603 | $5.39 | $3K | Direct | Jun 20, 2013 (1d) |
| Jun 17, 2013 | ALIM | ↓ Sell | 126,709 | $5.29 | $670K | Direct | Jun 18, 2013 (1d) |
| Jun 17, 2013 | ALIM | ↓ Sell | 1,384 | $5.29 | $7K | Direct | Jun 18, 2013 (1d) |
| Jun 11, 2013 | ALIM | ↓ Sell | 5,337 | $5.00 | $27K | Direct | Jun 13, 2013 (2d) |
| Jun 11, 2013 | ALIM | ↓ Sell | 59 | $5.00 | $295 | Direct | Jun 13, 2013 (2d) |
| Jun 4, 2013 | CLVS | ↓ Sell | 159,192 | $64.58 | $10.3M | Direct | Jun 5, 2013 (1d) |
| Jun 4, 2013 | CLVS | ↓ Sell | 2,779 | $64.58 | $179K | Direct | Jun 5, 2013 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About James C Blair's insider trades
James C Blair is a director at Clovis Oncology (CLVS). Since Jun 9, 2005, James has reported 66 open-market purchases worth $154.3M and 147 sales worth $77.8M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include other transactions (51 filings), conversions (50 filings), grants and awards (40 filings), shares returned to the company (11 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CLVS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.